Ladenburg Thalmann Financial Services’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | $579K | Sell |
3,934
-72
| -2% | -$10.6K | ﹤0.01% | 1683 |
|
2019
Q3 | $528K | Buy |
4,006
+631
| +19% | +$83.2K | ﹤0.01% | 1721 |
|
2019
Q2 | $480K | Buy |
3,375
+122
| +4% | +$17.4K | ﹤0.01% | 1781 |
|
2019
Q1 | $479K | Sell |
3,253
-215
| -6% | -$31.7K | ﹤0.01% | 1721 |
|
2018
Q4 | $394K | Buy |
3,468
+1,745
| +101% | +$198K | ﹤0.01% | 1713 |
|
2018
Q3 | $230K | Sell |
1,723
-175
| -9% | -$23.4K | ﹤0.01% | 2202 |
|
2018
Q2 | $203K | Hold |
1,898
| – | – | ﹤0.01% | 2220 |
|
2018
Q1 | $203K | Buy |
1,898
+375
| +25% | +$40.1K | ﹤0.01% | 2220 |
|
2017
Q4 | $167K | Buy |
1,523
+181
| +13% | +$19.8K | ﹤0.01% | 2335 |
|
2017
Q3 | $145K | Buy |
1,342
+548
| +69% | +$59.2K | ﹤0.01% | 2344 |
|
2017
Q2 | $80K | Buy |
794
+7
| +0.9% | +$705 | ﹤0.01% | 2656 |
|
2017
Q1 | $71K | Buy |
787
+353
| +81% | +$31.8K | ﹤0.01% | 2635 |
|
2016
Q4 | $35K | Sell |
434
-62
| -13% | -$5K | ﹤0.01% | 3100 |
|
2016
Q3 | $41K | Sell |
496
-38
| -7% | -$3.14K | ﹤0.01% | 2929 |
|
2016
Q2 | $44K | Buy |
534
+31
| +6% | +$2.55K | ﹤0.01% | 2769 |
|
2016
Q1 | $39K | Sell |
503
-10
| -2% | -$775 | ﹤0.01% | 2763 |
|
2015
Q4 | $40K | Buy |
513
+27
| +6% | +$2.11K | ﹤0.01% | 2728 |
|
2015
Q3 | $31K | Buy |
486
+41
| +9% | +$2.62K | ﹤0.01% | 2795 |
|
2015
Q2 | $31K | Sell |
445
-51
| -10% | -$3.55K | ﹤0.01% | 2920 |
|
2015
Q1 | $39K | Sell |
496
-8
| -2% | -$629 | ﹤0.01% | 2739 |
|
2014
Q4 | $35K | Buy |
504
+48
| +11% | +$3.33K | ﹤0.01% | 2587 |
|
2014
Q3 | $27K | Buy |
456
+36
| +9% | +$2.13K | ﹤0.01% | 2431 |
|
2014
Q2 | $22K | Buy |
420
+47
| +13% | +$2.46K | ﹤0.01% | 2582 |
|
2014
Q1 | $23K | Sell |
373
-38
| -9% | -$2.34K | ﹤0.01% | 2472 |
|
2013
Q4 | $22K | Hold |
411
| – | – | ﹤0.01% | 2469 |
|
2013
Q3 | $21K | Sell |
411
-212
| -34% | -$10.8K | ﹤0.01% | 2405 |
|
2013
Q2 | $27K | Buy |
+623
| New | +$27K | ﹤0.01% | 2150 |
|